A Study of Autologous Induced Islet Body With Type 1 Diabetes

NCT03728296 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-11-02

No results posted yet for this study

Summary

This is a single centre、single arm、open-label study,to investigate the safety and efficacy of Autologous induced islet body With Type 1 diabetes

Conditions

Interventions

BIOLOGICAL

islet body

Transplanting islet bodies under the diaphragm

Sponsors & Collaborators

  • Allife Medical Science and Technology Co., Ltd.

    lead INDUSTRY

Study Design

Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-31
Primary Completion
2020-01-31
Completion
2021-01-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03728296 on ClinicalTrials.gov